mark pruzanski  intercept pharmaceuticals inc  zoominfocom intercept pharmaceuticals  wikipedia intercept pharmaceuticals from wikipedia the free encyclopedia jump to navigation search coordinates °′″n °′″w﻿  ﻿°n °w﻿    intercept pharmaceuticals type public company traded as nasdaq icpt industry biotechnology founded  headquarters new york city new york united states key people mark pruzanski president and ceo jonathan silverstein chairman of the board of directors website wwwinterceptpharmacom intercept pharmaceuticals inc is an american biopharmaceutical company incorporated in  focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases such as primary biliary cirrhosis pbc now called primary biliary cholangitis nonalcoholic fatty liver disease or nonalcoholic steatohepatitis nash cirrhosis portal hypertension primary sclerosing cholangitis and also the intestinal disorder bile acid diarrhea productsedit the companys lead product is obeticholic acid oca also known as ethylchenodeoxycholic acid or int marketed as ocaliva oca is a potent firstinclass farnesoid x receptor fxr agonist as of march  ocaliva is approved in the us and the eu for use in primary biliary cholangitis it is in phase iii studies for nonalcoholic steatohepatitis nash and phase ii studies for primary sclerosing cholangitis other products in the development pipeline include int a dual fxrtgr agonist and int a tgr agonist initial public offering and stock historyedit intercept trades on the nasdaq exchange under the ticker symbol icpt the initial public offering of the stock on october   was at  a followon public offering at  took place on june   on january   the stock skyrocketed from  to  or about  after a planned interim analysis by the independent data safety monitoring board showed that obeticholic acid met the main goal improvement of liver histology at the midstage in the flint trial in nash sponsored by niddk the stock continued to climb to  over the next few days before falling back to around  on march   giving a market capitalization of around  billion in march  the company released the results of the poise study of obeticholic acid in pbc which showed the drug met the trials primary endpoint of a reduction in serum alkaline phosphatase a biomarker for the disease these results were presented at an international liver meeting in april  as of  december  the company had  employees referencesedit  intercept pharmaceuticals strong biopharmaceutical ipo seeking alpha october   retrieved    the farnesoid x receptor fxr ligand obeticholic acid in nash treatment trialflint   intercept pharma press release intercept announces nash primary endpoint met flint trial stopped early for efficacy based on highly statistically significant improvement in liver histology retrieved january     intercept pharma press release intercept announces positive pivotal phase  poise trial results retrieved march     intercepts liver disease drug proves highly effective in study reuters april   retrieved april     intercept pharmaceuticals form k annual report  retrieved october    external linksedit intercept pharmaceuticals website  v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitleinterceptpharmaceuticalsoldid categories companies listed on nasdaqbiotechnology companies of the united statespharmaceutical companies of the united stateshealth care companies based in new yorkhidden categories coordinates not on wikidatapages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view leadership  intercept pharmaceuticals inc careers partnering toggle navigation about  about intercept leadership board of directors contact us rd  fxr therapeutic areas pbc nash psc alcoholic hepatitis pipeline discovery compounds scientific presentations patient resources  pbc disease pbc patient stories investors  media  press releases events  presentations corporate governance leadership board of directors committee composition contact the board financial information sec filings annual reports quarterly results stock information historic stock lookup investment calculator dividend history analyst coverage investor faqs contact us  home investors  media corporate governance leadership leadership mark pruzanski md chief executive officer  president mark pruzanski md is a cofounder of the company and has served as our chief executive officer and president and has been a member of our board of directors since our inception in  he has over  years of experience in life sciences company management venture capital and strategic consulting dr pruzanski was previously a venture partner at apple tree partners an early stage life sciences venture capital firm he cofounded in  prior to that he was an entrepreneurinresidence at oak investment partners dr pruzanski received his md from mcmaster university in ontario an ma degree in international affairs from the johns hopkins university school of advanced international studies in bologna italy and washington dc and a bachelors degree from mcgill university in montreal quebec he currently also serves on the boards of the emerging company section of the biotechnology innovation organization bio and the foundation for the defense of democracies a think tank in washington dc dr pruzanski is a coauthor of a number of scientific publications and an inventor of several patents relating to our product candidates and scientific discoveries lisa bright president international lisa bright  is our president international she has over  years of experience in the biopharmaceutical industry ms bright previously served as our chief commercial and corporate affairs officer from february  through july  and joined intercept in november  as the head of europe prior to joining intercept ms bright worked at gilead sciences ltd starting in  where she held positions of increasing responsibility including general manager united kingdom  ireland vice president northern europe vice president head of sovaldi launch planning for europe asia middle east and australasia and vice president government affairs europe middle east and australasia prior to holding these positions ms bright held a range of senior positions at glaxosmithkline plc including vice president and managing director of new zealand and vice president — sales for the united kingdom ms bright has a bsc in pharmacology from university college london jerome durso chief operating officer jerome durso has served as our chief operating officer since february  mr durso brings nearly  years of experience in building and leading commercial and business operations at life sciences companies both in the united states and abroad  mr durso has spent the majority of his career at sanofi a global pharmaceutical company where he most recently served as senior vice president chief commercial officer of the global diabetes division from  through  from  to  mr durso was senior vice president chief commercial officer of sanofi’s us pharmaceuticals business prior to that he served in a number of commercial leadership roles of increasing responsibility in business unit and brand management marketing and sales since he first joined sanofi in   mr durso currently serves as an advisory board member of the robert wood johnson university hospital somerset in somerville new jersey mr durso earned his bachelor degree in marketing from the university of notre dame david ford chief human resources officer david ford is our chief human resources officer he brings over  years of experience in a variety of human resources roles across the united states europe latin america and new zealand prior to joining intercept mr ford spent nearly  years at sanofi where most recently he served as vice president human resources for the sanofi genzyme global business unit starting in  prior to that role from  until  mr ford served as vice president human resources for the sanofi north american businesses mr ford joined the pharmaceutical industry in  as the hr director – united kingdom and republic of ireland for sanofisynthelabo mr ford holds a master’s degree in business administration from insead fontainebleau france sandip kapadia chief financial officer sandip s kapadia has served as our chief financial officer since july  mr kapadia brings over  years of experience in building and leading finance and administration teams at life sciences companies both in the united states and abroad mr kapadia joins intercept from sandoz inc a division of novartis ag where he served as vice president and chief financial officer — north america from  through  from  to  mr kapadia was vice president and chief financial officer of novartis pharmaceuticals uk limited mr kapadia also served as vice president and chief financial officer of novartis pharmaceuticals bv located in the netherlands from  through  prior to that he served as head of finance — oncology business unit for both novartis pharmaceuticals ag and novartis pharmaceuticals corporation mr kapadia earned his bachelor degree in business administration and accounting from montclair state university an mba from rutgers graduate school of management and is a certified public accountant richard kim senior vice president us commercial richard kim has served as our senior vice president commercial us since july  he has over  years of commercial marketing and managerial experience in the biopharmaceutical industry in the united states and abroad prior to joining intercept mr kim worked at bristolmyers squibb starting in  where he most recently served as general manager hepatitis c worldwide commercialization prior to that mr kim held a number of roles of increasing responsibility at bristolmyers squibb including vice president sprycel brand lead oncology global marketing vice president us inline oncology and global marketing for necitumumab and vice president east area sales cardiovascular and metabolics prior to holding these positions mr kim held a range of senior positions in the united states canada and australia at scheringplough which was acquired by merck  co mr kim earned his bachelor degree in chemistry from the university of alberta rachel mcminn phd chief business and strategy officer rachel mcminn phd has served as our chief business and strategy officer since march  dr mcminn joined intercept as chief strategy officer in  since  until joining intercept she was a managing director at bank of america merrill lynch working as the lead research analyst covering the biotechnology industry previously dr mcminn worked at cowen and company as a lead biotechnology analyst and started her career as a biotechnology analyst at piper jaffray  co she graduated magna cum laude with a bachelor of arts degree in chemistry from cornell university earned a phd in molecular and cellular biology and chemistry from the scripps research institute and was awarded a postdoctoral miller fellowship at the university of california at berkeley david shapiro md chief medical officer  executive vice president development david shapiro md has served as our chief medical officer and executive vice president development since  he has over  years of clinical development experience in the pharmaceutical industry dr shapiro founded a consulting company integrated quality resources that focused on development stage biopharmaceutical companies and was active in this role from  to  from  to  dr shapiro was executive vice president medical affairs and chief medical officer of idun pharmaceuticals inc prior to its acquisition by pfizer from  to  he was president of the scripps medical research center at scripps clinic he also served as vice president clinical research at gensia and as director and group leader hypertension clinical research at merck research laboratories from  to  dr shapiro has authored more than  peerreviewed publications and organized and chaired several conferences aimed at improving product development he received his medical degree from dundee university  medical school and undertook his postgraduate medical training in the university affiliated hospitals in oxford united kingdom and the university of vermont dr shapiro served on the board of directors of altair therapeutics and served for two terms on the executive committee of the board of the american academy of pharmaceutical physicians he is an elected fellow of both the royal college of physicians of london and the faculty of pharmaceutical physicians of the united kingdom investors  media press releases events  presentations corporate governance leadership board of directors committee composition contact the board financial information stock information contact us shareholder tools briefcase email alerts download library snapshot rss print share facebook google linkedin twitter email rss website privacy policy privacy shield policy terms of use contact us glossary  hudson yards th floor  new york ny   t icpt   intercept pharmaceuticals inc icpt mark e pruzanski insider trades for intercept pharmaceuticals inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close intercept pharmaceuticals inc nasdaq icpt go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus intercept pharmaceuticals inc after hours  quotes are delayed by  min jul    pm icpt quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual mark e pruzanski dr mark e pruzanski md is founder at kirax corp and president chief executive officer  director at intercept pharmaceuticals inc he is on the board of directors at intercept pharmaceuticals inc gicare pharma inc biotechnology industry organization and foundation for the defense of democracies dr pruzanski was previously employed as chief executive officer by medicineplanet inc entrepreneurinresidence by oak investment partners and venture partner by apple tree partners he received his undergraduate degree from mcgill university a graduate degree from the paul h nitze school of advanced international studies it and a doctorate degree from mcmaster university transactions date shares transaction value     disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      award at  per share      disposition at  per share      gift at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      award at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      gift at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      gift at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr mark e pruzanski president chief executive officer  director mr jerome b durso chief operating officer mr sandip s kapadia chief financial officer dr david a shapiro chief medical officer  executive vpdevelopment mr richard kim senior vice presidentcommercial head of us dr juan carlos lopeztalavera senior vice presidenthead medical affairs ms lisa bright presidentinternational dr rachel l mcminn chief business  strategy officer mr christopher frates media contact dr mark j vignola directorinvestor relations mr paolo fundarò chairman dr keith m gottesdiener independent director mr daniel mark bradbury independent director mr daniel g welch independent director mr gino santini independent director dr luca benatti independent director mr glenn p sblendorio independent director dr srinivas akkaraju independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ahow to curb your social media addiction aa bright picture for netflix aeuropean stocks drop to month low as ubs falls tech worries weigh amerck profit and sales rise beat expectations amid big jump in keytruda sales aao smith’s bet on china’s airpollution problem is paying off aexxon earnings will stock trade higher on expected secondquarter beat afoxconn’s history of broken promises casts a shadow on wisconsin news ahigh times is going public through a deal with a blankcheck company — and here’s what that means aintel earnings have message for amd and nvidia ‘bring it on’ aamazon’s freespending ways hit earnings but don’t expect a shift to thrift amerck q januviajanumet revenue  bln vs  bln factset consensus  bln amerck q keytruda sales  mln vs  mln a year ago factset consensus  mln amerck raises  revenue outlook to  bln bln from  bln bln amerck affirms  adj eps outlook of  amerck q revenue  bln vs  bln factset consensus  bln amerck q adj eps  factset consensus  cents amerck q eps  cents vs  cents a year ago arussia retaliates to new sanctions by telling us to cut diplomats aget ready for the lessprofitable amazon that you used to know athis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  phasti trademark of pruzansky mark serial number   trademarkia trademarks apply online attorneys services us trademark registration service international trademark registration service trademark office action response trademark statement of use trademark renewal trademark assignment trademark watch trademark cease  desist trademark comprehensive search copyright registration patent services incorporation services business page creation more services help contact us login trademark search trademark category computer  software services  scient phasti   get free email alerts phasti trademark information pruzansky mark medical services namely orthopaedics orthopaedic surgery hand surgery plastic surgery of arms legs and torso microsurgery sports medicine rehabilitation therapy and occupational therapy perfect for these industries computer  software services  scientific services words that describe this mark medical   services       orthopaedics   orthopaedic   surgery   hand   surgery   plastic   surgery   arms     legs     torso   microsurgery   sports   medicine   rehabilitation   therapy   occupational   therapy   this is a brand page for the phasti trademark by pruzansky mark  in new york ny  write a review about a product or service associated with this phasti trademark or contact the owner pruzansky mark of the phasti trademark by filing a request to communicate with the legal correspondent for licensing use andor questions related to the phasti trademark on wednesday july   a us federal trademark registration was filed for phasti by pruzansky mark new york ny  the uspto has given the phasti trademark serial number of  the current federal status of this trademark filing is registered and renewed the correspondent listed for phasti is jeffrey s steen of carter deluca farrell and schmidt llp  broad hollow road suite  melville ny   the phasti trademark is filed in the category of computer  software services  scientific services  the description provided to the uspto for phasti is medical services namely orthopaedics orthopaedic surgery hand surgery plastic surgery of arms legs and torso microsurgery sports medicine rehabilitation therapy and occupational therapy word mark phasti statusstatus date registered and renewed  serial number  filing date  registration number  registration date  goods and services medical services namely orthopaedics orthopaedic surgery hand surgery plastic surgery of arms legs and torso microsurgery sports medicine rehabilitation therapy and occupational therapy mark description not available type of mark service mark published for opposition date  last applicantowner pruzansky marknew york ny  why is this contact information displayed why is this contact information displayed close the uspto makes this data available for search by the public so that individuals can locate ownership information for intellectual property much the same way a county might make real estate property ownership information available since our website is synchronized with the uspto data we recommend making any data changes with the uspto directly our website will autoupdate when the uspto data is updated you may also contact trademarkia to make a request for the removal of your personally identifiable information or trademark data such requests must be made in writing and will be subject to verification of ownership this policy allows verified trademark owners to specify a that their identifiable information be masked or b that their trademark pages permanently deleted from trademarkiacom requests may be made directly to customerservicetrademarkiacom and every effort will be made to honor them within  hours click here for further details close mark drawing code typeset wordsletternumber design search no data register type principal disclaimer not available correspondent jeffrey s steen carter deluca farrell and schmidt llp  broad hollow road suite  melville ny  use in commerce trademark  applicant has provided proof of use of this mark in commerce to uspto classification information primary class class   scientific and technological services and research and design relating thereto industrial analysis and research services design and development of computer hardware and software first use anywhere  first use in commerce  trademarkia is the largest search engine for us trademarks each month hundreds of trademarks around the world are filed by licensed attorneys in the legalforcetrademarkia network you can register your trademark in  countries in the world through legalforce network legalforce network can help you incorporate a business around your phasti trademark in less than  minutes trademarkia makes the process easy and convenient so start now trademarkiacom is a free search engine of publicly available government records trademarkiacom is not a law firm and does not represent owners  correspondents listed on this page trademark document retrieval  trademark  apply online  satisfaction guarantee protect your valuable brand now how it works what you get  legalforce rapc   us trademark filing from  to now  describe how your business or product is being used register your mark in  countries just   govt fees start here   top global ip attorneys  credibility and experience  all processes will be performed in a timely manner you will be informed periodically about the process keep track of this brand trademark watch services keep track of how your trademark is being used available in the united states and in more than  countries roundtheclock monitoring monthly report on potential infringement watch this trademark trademark watch services read more current trademark status  registered and renewed free trademark search correspondent search jeffrey s steen is a correspondent of phasti trademark current overall rating  review what you can do start your business free logo creator add to favorites view documents free trademark search start trademark filing process protect this mark internationally custom logo design  search phasti on popular social networks trademarkia lets you see how your personal name product name trademark name or username is being used on any of  new and popular social networks be the first to reserve your name and get help stopping others from using it  all in one place trademark oppose service you can request for extension of time to oppose this mark or oppose it now  if you are new to legalforcetrademarkia please just enter your contact email and create a password  if you already have a legalforcetrademarkia account please enter your accounts email and password  email address please enter your email address  enter password please enter your password  please enter the value       status update alerts status update alerts are email updates of the latest trademark status change please make sure you provide the correct email  if you are new to legalforcetrademarkia please just enter your contact email and create a password  if you already have a legalforcetrademarkia account please enter your accounts email and password  email address please enter your email address  enter password please enter your password  please enter the value       review  rating please rate and review for phasti phasti is providing medical services namely orthopaedics orthopaedic surgery hand surgery plastic surgery of arms legs and torso microsurgery sports medicine rehabilitation therapy and occupational therapy  if you are new to legalforcetrademarkia please just enter your contact email and create a password to be associated with your review if you already have a legalforcetrademarkia account please enter your accounts email and password before posting your review  please rate        your review please enter your review  email address please enter your email address  enter password please enter your password       mark pruzanski md  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in mark pruzanski md president chief executive officer and director at intercept pharmaceuticals inc view full profile are you mark pruzanski md claim your profile   sign up for equilar atlas and view mark pruzanski mds full profile with equilar atlas you can identify corporate executives in mark pruzanski mds network and community follow changes in mark pruzanski mds employment and moneyinmotion connect with mark pruzanski md through your network of contacts mark pruzanski mds executive work history current president chief executive officer and director intercept pharmaceuticals inc past to view mark pruzanski mds complete executive work history sign up now age      mark pruzanski mds biography mark pruzanski md is a cofounder of our company and has served as our chief executive officer and president and has been a member of our board of directors since our inception in  he has over  years of experience in life sciences company management venture capital and strategic consulting dr pruzanski was previously a venture partner at apple tree partners an early stage life sciences venture capital firm he cofounded in  prior to that he was an entrepreneurinresidence at oak investment partners dr pruzanski received his md from mcmaster university in ontario a ma degree in international affairs from the johns  read more mark pruzanski md is a cofounder of our company and has served as our chief executive officer and president and has been a member of our board of directors since our inception in  he has over  years of experience in life sciences company management venture capital and strategic consulting dr pruzanski was previously a venture partner at apple tree partners an early stage life sciences venture capital firm he cofounded in  prior to that he was an entrepreneurinresidence at oak investment partners dr pruzanski received his md from mcmaster university in ontario a ma degree in international affairs from the johns hopkins university school of advanced international studies in bologna italy and washington dc and a bachelors degree from mcgill university in montreal quebec he currently also serves on the boards of the emerging company section of the biotechnology industry association bio and the foundation for the defense of democracies a think tank in washington dc dr pruzanski is a coauthor of a number of scientific publications and an inventor of several patents relating to our product candidates and scientific discoveries we believe that dr pruzanskis perspective and the experience he brings as our chief executive officer and president and as one of our companys founders together with his historic knowledge of our company and our products and product candidates operational expertise and continuity to our board of directors and his experience in managing and investing in companies within the life sciences industry qualify him to serve as a member of our board of directors source intercept pharmaceuticals inc on    sign up for equilar atlas and view mark pruzanski mds full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like mark pruzanski md more specifically youll be able to identify corporate executives in mark pruzanski mds network and community follow changes in mark pruzanski mds employment and moneyinmotion connect with mark pruzanski md through your network of conections view full profile   search for over  executive profiles bio example mark pruzanski md mark pruzanski mds connections  sign up now to view mark pruzanski mds  connections » paul j hastings chairman of the board chief executive officer and president oncomed pharmaceuticals inc kleanthis g xanthopoulos board member apricus biosciences inc stuart a arbuckle executive vice president and chief commercial officer vertex pharmaceuticals incorporated srinivas akkaraju board member seattle genetics inc peter m kash former board member capricor therapeutics inc steven j mento dir president chief executive officer and acting principal financial officer conatus pharmaceuticals inc john a orwin dir president and chief executive officer relypsa inc andrew a hindman chief business development officer acorda therapeutics francois nader chairman of the board acceleron pharma inc john f crowley chairman of the board and chief executive officer amicus therapeutics inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   mark pruzanski  cofounder at intercept pharmaceuticals inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink mark pruzanski cofounder at intercept pharmaceuticals inc overview in the news relationships paths education memberships career history boards  committees nonprofit donations  grants political donations investments public holdings transactions mark pruzanski cofounder at intercept pharmaceuticals inc overview age  born  notable companies medicineplanet inc intercept pharmaceuticals inc kirax corporation board seats  number of relationships this person is connected to  people in the news see more relsci march   mark pruzanski is no longer serving in their board position at evelo biosciences inc globenewswire september   intercept pharmaceuticals files new drug submission to health canada for marketing approval of obeticholic acid for the treatment of patients with primary biliary cholangitis pr newswire july   evelo biosciences and epiva biosciences merge to create the leading immunomicrobiome platform company globenewswire june   intercept pharmaceuticals appoints sandip kapadia as chief financial officer globenewswire october   intercept pharmaceuticals announces results of phase  trial of oca in nash patients in japan see full news coverage and complete stories with relsci professional create your news feed see more relationships see details paolo fundaro chief financial officer  general manager at genextra spa james mervis managing director at bioscience strategies nz ltd clifford d may president at foundation for the defense of democracies inc luca benatti chief executive officer at erydel spa glenn p sblendorio president  chief executive officer at ophthotech corp daniel g welch executive partner private equity at sofinnova ventures inc gino santini former president us operations at eli lilly  company joshua a kazam cofounder at two river group holdings llc barbara h wells director  vice chairmanfood governing body at biotechnology innovation organization srinivas akkaraju professional at samsara biocapital llc see  more listings with relsci professional start my free trial ➤ see  more paths to mark pruzanski mark pruzanski you connections via relationship science mark pruzanski sync your contacts to see how you can connect with mark pruzanski start my free trial ➤ see more educational background ma in international affairs  paul h nitze school of advanced international studies it bachelors degree  mcgill university mcgill university is a public research university located in montreal quebec canada founded in  during the british colonial era the university bears the name of james mcgill a prominent montreal merchant from glasgow scotland and alumnus of glasgow university whose bequest formed the beginning of the university md  mcmaster university  faculty of health sciences memberships member current biotechnology industry association career history cofounder   current intercept pharmaceuticals inc intercept pharmaceuticals is a biopharmaceutical company which engages in the research development and commercialization of novel therapeutics in treating chronic liver diseases its product pipeline is ocaliva which is used for the treatment of primary biliary cholangitis nonalcoholic steatohepatitis primary sclerosing cholangitis and biliary atresia the company was founded by mark e pruzanski and roberto pellicciari on september   and is headquartered in new york ny founder    kirax corporation kirax corp researches develops manufactures and distributes pharmaceutical products the firm provides specialty care therapies to treat oncology pain inflammation acute and supportive care areas of unmet medical need the company was founded by mark e pruzanski david m tanen and edmundo muniz in  and is headquartered in bonita springs fl cofounder   prior apple tree partners apple tree partners invests in biopharmaceutical and medical device companies they look for companies with proprietary products and technologies with the potential to serve markets with unmet needs the firm prefers to start companies but they do consider companies at all stages of development apple tree partners seeks to leverage their capital through syndication with larger venture firms corporate partnering and innovative financing approaches chief executive officer prior medicineplanet inc entrepreneurinresidence prior oak investment partners oak investment partners is a multistage venture capital firm oak focuses on highgrowth opportunities in the information technology internet and consumer financial services technology healthcare information and services and clean energy sectors their goal is to help dynamic companies transform the way business is done boards  committees corporate boards ▾ member board of directors   current intercept pharmaceuticals inc intercept pharmaceuticals is a biopharmaceutical company which engages in the research development and commercialization of novel therapeutics in treating chronic liver diseases its product pipeline is ocaliva which is used for the treatment of primary biliary cholangitis nonalcoholic steatohepatitis primary sclerosing cholangitis and biliary atresia the company was founded by mark e pruzanski and roberto pellicciari on september   and is headquartered in new york ny member board of directors    evelo biosciences inc evelo biosciences inc develops oncobiotic therapeutics for cancer it develops immunotherapies for the treatment of cancer autoimmune and inflammatory diseases the company was founded by noubar b afeyan and david a berry in  and is headquartered in cambridge ma director prior gicare pharma inc gicare pharma inc develops gastrointestinal drugs it develops orallyadministered drug gic which provides colonic analgesia the company was founded by patrick colin and maxime ranger in  and is headquartered in montreal canada nonprofit boards ▾ chairman  director current foundation for the defense of democracies inc to conduct research and provide education on international terrorism and related issues member international council of advisors current national geographic society the national geographic society has been inspiring people to care about the planet since  it is one of the largest nonprofit scientific and educational institutions in the world its interests include geography archaeology and natural science and the promotion of environmental and historical conservation member emerging companies section governing board current biotechnology innovation organization biotechnology innovation organization is the worlds biotechnology organization providing advocacy business development and communications services for more than  members worldwide bio members are involved in the research and development of innovative healthcare agricultural industrial and environmental biotechnology technologies corporate members range from entrepreneurial companies developing a first product to fortune  multinationals also represent state and regional biotech associations service providers to the industry and academic centers nonprofit donations  grants    new york philharmonic new york philharmonic provides live theatrical presentations the company was founded in  and is headquartered in new york ny    new york philharmonic new york philharmonic provides live theatrical presentations the company was founded in  and is headquartered in new york ny    new york philharmonic new york philharmonic provides live theatrical presentations the company was founded in  and is headquartered in new york ny    new york philharmonic new york philharmonic provides live theatrical presentations the company was founded in  and is headquartered in new york ny    new york philharmonic new york philharmonic provides live theatrical presentations the company was founded in  and is headquartered in new york ny see  more listings with relsci professional start my free trial ➤ see  more political donations   john kerry former senator from massachusetts investments details hidden kirax corporation kirax corp researches develops manufactures and distributes pharmaceutical products the firm provides specialty care therapies to treat oncology pain inflammation acute and supportive care areas of unmet medical need the company was founded by mark e pruzanski david m tanen and edmundo muniz in  and is headquartered in bonita springs fl details hidden intercept pharmaceuticals inc intercept pharmaceuticals is a biopharmaceutical company which engages in the research development and commercialization of novel therapeutics in treating chronic liver diseases its product pipeline is ocaliva which is used for the treatment of primary biliary cholangitis nonalcoholic steatohepatitis primary sclerosing cholangitis and biliary atresia the company was founded by mark e pruzanski and roberto pellicciari on september   and is headquartered in new york ny public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden intercept pharmaceuticals inc issued common stock details hidden intercept pharmaceuticals inc raised money in a private placement transaction other affiliations mark pruzanski is affiliated with intercept pharmaceuticals inc kirax corporation apple tree partners medicineplanet inc oak investment partners intercept pharmaceuticals inc evelo biosciences inc gicare pharma inc foundation for the defense of democracies inc national geographic society biotechnology innovation organization youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ hand surgeon in new york city  hand and wrist surgery in nyc dr mark e pruzanskyhandsport surgery institutemark e pruzansky md is a seasoned specialist in hand surgery and microsurgery sports injuries and arthroscopic and reconstructive surgery of the hand wrist elbow and brachial plexus park avenuenew yorknew yorkusinfohandsportusphone  dr mark e pruzansky dr jason s pruzansky  park avenue new york new york request a consultationcall us  main menu skip to primary content skip to secondary content the leader in hand  upperextremity surgery dr pruzansky repairs hands wrists and elbow problems using minimally invasive surgery loading quotes more testimonials » contact us specialties include hand conditions and injuriesspecialties include wrist conditions and injuriesspecialties include hand conditions and injuriesspecialties include wrist conditions and injuries more awards and recognition » meet the hand surgeons dr mark e pruzansky director dr jason s pruzansky new york citys premier hand and wrist surgeons handsport® surgery institute is the manhattan new york based practice of hand surgeons mark e pruzansky md a pioneer in the field of hand surgery wrist surgery and elbow surgery and jason s pruzansky md an expert hand and upper extremity surgeon noted for his work in traumatology reconstructive and microsurgery handsport surgery institute is one of the country’s leading practices for minimally invasive surgery providing patients with a quicker and less painful recuperation than with conventional surgeries endoscopic carpal tunnel release is one example of the extensive experience dr mark pruzansky and dr jason pruzansky possess with over  successful procedures completed to date we are dedicated to optimizing our patients’ lifestyles during every consultation and surgical procedure we focus on the details outcomes of both surgical and nonsurgical treatments are measured and compared using internationally recognized metrics choose the leading hand and wrist surgery group in nyc awarded three board certifications – hand surgery orthopaedic sports medicine and orthopaedic surgery – dr mark pruzansky is one of very few elite surgeons in the us and the world  june  who have earned all of these distinctions and seamlessly blend the principles of sports medicine into the specialty of hand and upper extremity surgery conditions treated include carpal tunnel syndrome wrist fractures ligament injuries of the hand and wrist nonunions and arthritis disorders and arthritis of the hand wrist and thumb tennis elbow and nerve injuries of the hand and upper extremity including the brachial plexus dr jason s pruzansky specializes in the diagnosis and treatment of injuries and conditions of the hand wrist forearm and elbow his expertise extends to integrating digital technology and orthopedic outcome measures to optimize nonsurgical and surgical treatment regimens understanding that successful outcomes requires detailed comprehension of a patient’s occupation sports hobbies and personal goals dr pruzansky engages his patients with respect and detailed discussion during office visits to create their plan of care and maximize their performance award winning hand surgeons named one of the tristate region’s finest hand surgeons in us news  world report magazine’s medical peerreviewed “best doctors” issue  dr mark pruzansky provides patients with innovative diagnostic and surgical techniques as well as respect and compassion included among these techniques are wrist and microsurgical nerve reconstruction arthroscopic hand and upper extremity surgery and wrist fractures and scaphoid nonunions complex reconstructions including revision surgery are referred to the practice for evaluation and treatment dr jason pruzansky utilizes minimally invasive surgical techniques for a range of treatments from wrist ligament repair to endoscopic carpal tunnel release allowing patients to have generally a less painful and faster recovery than conventional techniques he has won numerous national awards including scoring in the th percentile of all orthopaedic surgery residents nationally while at mount sinai medical center he was recently named a superdoctors new york rising star for  dr jason pruzansky has also been recognized as a diplomat of the national board of medical examiners is a member of the american orthopaedic association emerging leaders program and recipient of mount sinai’s shining star award for excellence in patient care he has been published frequently in leading medical journals and has presented nationally his clinical research handsport surgery institutehours of operation mon through fr am  pm park avenuenew york new yorkusinfohandsportusphone  dr mark e pruzansky dr mark e pruzanskyhandsport surgery institutemark e pruzansky md is a seasoned specialist in hand surgery and microsurgery sports injuries and arthroscopic and reconstructive surgery of the hand wrist elbow and brachial plexus park avenuenew yorknew yorkusinfohandsportusphone  dr mark e pruzansky dr jason s pruzansky  park avenue new york new york request a consultationcall us  main menu skip to primary content skip to secondary content about handsport® dr mark e pruzansky dr jason s pruzansky mission vision  principles publications hospitals awards  recognition dr mark e pruzansky dr mark e pruzansky director of handsport surgery institute is a seasoned specialist in hand surgery wrist surgery and microsurgery sports injuries and arthroscopic and reconstructive surgery of the hand wrist elbow and brachial plexus  with more than  years of highlevel practice and a comprehensive knowledge of the body’s biomechanical linkages dr pruzansky is able to diagnose patients using a “kineticchain approach” that reveals underlying—and often overlooked—issues coming from other parts of the musculoskeletal system with three board certifications in surgery of the hand orthopaedic sports medicine and orthopaedic surgery  of hand surgeons worldwide july  dr pruzansky is uniquely able to diagnose and treat hand and upper extremity conditions that are specific to elite and amateur athletes in addition to those afflicting almost everyone in any occupation including retirement one of the country’s most experienced practitioners of  endoscopic carpal tunnel release surgery—over  cases—and a pioneer in the treatment of tennis elbow dr pruzansky is dedicated to the delivery of stateofthe art surgical and medical treatment as well as supervising the patient’s occupational and physical therapy his expertise in solving difficult problems of the hand wrist and upper extremity is often sought and he has been a hand surgery consultant to wabctv with appearances on eyewitness news complex reconstructions including revision surgery are referred to the practice for evaluation and treatment dr pruzansky graduated with honors from both columbia college and the mount sinai school of medicine and orthopaedic program in new york he was a hand surgery fellow in san francisco where he was certified in microsurgery and studied under one of the country’s most renowned pioneers of joint replacements for arthritic fingers and wrists while a hand surgery fellow in new orleans dr pruzansky studied with one of the fathers of adult reconstructive hand and wrist surgery who was also a founder of congenital deformities surgery he then furthered his studies in sports medicine and treatment of sportsrelated injuries of the hand and upper extremity at the southern california orthopaedic institute in van nuys in addition to being the director of the handsport® surgery institute dr pruzansky is affiliated with mount sinai medical center and medical school and lenox hill hospital he is a faculty lecturer at mount sinai medical center and has spoken on the national and regional levels to medical students residents and physicians  also to his credit dr pruzansky is a leading research fundraiser and a member of the american academy of orthopaedic surgeons the american society for surgery of the hand the international federation of societies for surgery of the hand the new york society for surgery of the hand and the orthopaedic research society dr pruzansky has published numerous articles on hand surgery and sports medicine in scientific journals and textbooks and is renowned for his clinical research teaching and pioneering of webbased patient education an athlete himself he plays tennis and golf downhill skis does cardio and lifts named one of the tristate region’s finest hand surgeons in new york magazine’s medical peerreviewed “best doctors”  issue dr pruzansky provides patients with innovative diagnostic and surgical techniques as well as respect and compassion schedule an appointment your nameemailphone numberappointment date time  hour minute am pm hand surgeon dr mark e pruzansky md is certified in hand surgery and orthopaedic sports medicine in addition to orthopaedic surgery by the american board of orthopaedic surgery the doctor is a member of the orthopaedic research society and has received the physicians recognition award from the american medical association a member of the assh aaos and the international federation of societies for the surgery of the hand dr mark e pruzanskyhandsport surgery institutehandsport® surgery institute is the manhattan based practice of hand surgeon mark e pruzansky md a pioneer in the field of hand surgery and upper extremity surgery including sports injuries park avenuenew yorknew yorkusinfohandsportusphone  handsport surgery institutehours of operation mon through fr am  pm park avenuenew york new yorkusinfohandsportusphone  mark pruzanski founder chief executive officer president and director intercept pharmaceuticals timesjavascript is disabled market profiles login sign up login sign up   edit person mark pruzanski founder chief executive officer president and director at intercept pharmaceuticals location new york ny add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop mark pruzanski founder chief executive officer president and director at intercept pharmaceuticals location new york ny add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop mark pruzanski md is a cofounder of the company and has served as our chief executive officer and president and has been a member of our board of directors since our inception in  he has over  years of experience in life sciences company management venture capital and strategic consulting dr pruzanski was previously a venture partner at apple tree partners an early stage life sciences venture capital firm he cofounded in  prior to that he was an entrepreneurinresidence at oak investment partners dr pruzanski received his md from mcmaster university in ontario an ma degree in international affairs from the johns hopkins university school of advanced international studies in bologna italy and washington dc and a bachelor’s degree from mcgill university in montreal quebec he currently also serves on the boards of the emerging company section of the biotechnology industry association bio and the foundation for the defense of democracies a think tank in washington dc dr pruzanski is a coauthor of a number of scientific publications and an inventor of several patents relating to our product candidates and scientific discoveries  companies in career na related markets  colleagues na related investments alias na industry pharmaceutical and medicine manufacturing tags na topics of influence web site na careers achievements investments related people edit view all mark pruzanskicareer   intercept pharmaceuticals founder chief executive officer president and director apple tree partners venture partner oak investment partners entrepreneurinresidence competencies edit view all mark pruzanskieducation  mcmaster university medicine johns hopkins university international affairs mcgill university arts edit mark pruzanskiachievements and recognitions add milestone no milestones has been recorded for mark pruzanski edit mark pruzanskilinks add link no links has been recorded for mark pruzanski mark pruzanskiinvestmentsacquisitions no investments has been recorded for mark pruzanski mark pruzanskiinvestments representing others no investment reps has been recorded for mark pruzanski mark pruzanskirelated people colleagues at intercept pharmaceuticals rachel mcminn chief strategy officer apr sanj k patel board of director feb rachel mcminn chief strategy officer mark pruzanski chief executive officer  president view all mark pruzanskirecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies